Diagnosis and definition of treatment-resistant depression
The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
Treatment-resistant depression (TRD) typically refers to inadequate response to at least one antidepressant trial of adequate doses and duration. TRD is a relatively common occurrence in clinical practice, with up to 50% to 60% of the patients not achieving adequate response following antidepressant treatment. A diagnostic re-evaluation is essential to the proper management of these patients. In particular, the potential role of several contributing factors, such as medical and psychiatric comorbidity, needs to be taken into account. An accurate and systematic assessment of TRD is a challenge to both clinicians and researchers, with the use of clinician-rated or self-rated instruments being perhaps quite helpful. It is apparent that there may be varying degrees of treatment resistance. Some staging methods to assess levels of treatment resistance in depression are being developed, but need to be tested empirically.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“About 30% of patients with major depression fail to achieve remission despite treatment with multiple antidepressants and are considered to have treatment-resistant depression (2).”
In the citing paper
“Approximately one-third of patients with major depressive disorder (MDD) do not achieve an antidepressant response despite treatment with multiple antidepressants and are considered to have treatment-resistant depression (TRD) [1, 2].”
In the citing paper
“Yet, the iatrogenic effects of treatment are carefully avoided in the literature on treatment resistance in depression [4].”
From The Deceptive Manifestations of Treatment Resistance in Depression: A New Look at the Problem (2020) · cites this paper as [4]
In the citing paper
“However, current conceptualizations of treatment resistance focus on the characteristics of the patient (whether neurobiological assets, or attitudes, or psychiatric comorbidity) for the insufficient effectiveness of antidepressant drugs and omit any reference to the potential iatrogenic effects of treatment [4]”
From The Deceptive Manifestations of Treatment Resistance in Depression: A New Look at the Problem (2020) · cites this paper as [4]
In the citing paper
“Fava and Rafanelli [4] have applied the concept of cascade iatrogenesis, that originated in geriatrics [44], to psychiatric settings.”
From The Deceptive Manifestations of Treatment Resistance in Depression: A New Look at the Problem (2020) · cites this paper as [4]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
The Inventory of Depressive Symptomatology (IDS): Psychometric properties
Rush, A. J., Gullion, C. M., Basco, M. R., Jarrett, R. B., & Trivedi, M. H. (1996) · Psychological Medicine · doi:10.1017/s0033291700035558 · Cited by 2,177
Frank, E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810330075011 · Cited by 1,959
Internal consistencies of the original and revised beck depression inventory
Beck, A. T., & Steer, R. A. (1984) · Journal of Clinical Psychology · doi:10.1002/1097-4679(198411)40:6<1365::aid-jclp2270400615>3.0.co;2-d · Cited by 1,146 · cited 1×
“While the use of clinician-rated instruments is preferred (see below), it is more common for clinician to use clinician global assessments, often combined with self-rated instruments, such as the Inventory of Depressive Symptomatology –Self-Rated (IDS-SR) (Rush et al 1996), the Beck Depression Inventory (BDI) in its o…”
MethodDEFINITION AND EPIDEMIOLOGY OF TREATMENT-RESISTANT DEPRESSION
Fava, M., & Davidson, K. G. (1996) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70283-5 · Cited by 797 · cited 5×
“, failure to achieve remission) to at least one antidepressant trial of adequate dose and duration (Fava and Davidson 1996).”
BackgroundMethodInfluentialSelf-citation(2001) · PubMed · Cited by 780
(1997) · PubMed · Cited by 727
The Prognosis of Depression in Old Age
Murphy, E. (1983) · British Journal of Psychiatry · doi:10.1192/bjp.142.2.111 · Cited by 618
Judd, L. L., Akiskal, H. S., Maser, J. D., Zeller, P. J., Endicott, J., Coryell, W., Paulus, M. P., Kunovac, J. L., Leon, A. C., Mueller, T. I., et al. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00138-4 · Cited by 590
Research works printed but not linked: 4
- Bakish, 2001, New standard of depression treatment, J Clin Psychiatry, 62, 5
- Papakostas GI, Petersen T, Iosifescu DV, Roffi P, Alpert JE, Rosenbaum JF, et al (in press b): Axis III co-morbidity in treatment-resistant depression. Psychiatry Research
- Papakostas GI, Petersen T, Mischoulon D, Alpert JE, Fava M, Nierenberg AA (in press a): Functioning and interpersonal relationships as predictors of response in treatment resistant depression. Comprehensive Psychiatry
- Thase, 1997, When at first you don’t succeed, J Clin Psychiatry, 58, 23
Cited by
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Deep Brain Stimulation for Treatment-Resistant Depression
Mayberg, H. S., Lozano, A. M., Voon, V., McNeely, H. E., Seminowicz, D., Hamani, C., Schwalb, J. M., & Kennedy, S. H. (2005) · Neuron · doi:10.1016/j.neuron.2005.02.014 · Cited by 4,059
“While depression can be effectively treated in the majority of patients by either medication or some form of evidence-based psychotherapy (American Psychiatric Association, 2000), up to 20% of patients fail to respond to standard interventions (Fava, 2003; Keller et al., 1992).”
InfluentialKelly, J. R., Borre, Y., O' Brien, C., Patterson, E., El Aidy, S., Deane, J., Kennedy, P. J., Beers, S., Scott, K., Moloney, G., et al. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.07.019 · Cited by 1,683
“Current pharmacological interventions are suboptimal (Fava, 2003) and there has been little progress in the identification of biomarkers.”
BackgroundPopova, V., Daly, E. J., Trivedi, M., Cooper, K., Lane, R., Lim, P., Mazzucco, C., Hough, D., Thase, M. E., Shelton, R. C., et al. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19020172 · Cited by 904
McIntyre, R. S., Alsuwaidan, M., Baune, B. T., Berk, M., Demyttenaere, K., Goldberg, J. F., Gorwood, P., Ho, R., Kasper, S., Kennedy, S. H., et al. (2023) · World Psychiatry · doi:10.1002/wps.21120 · Cited by 836
Metadata
- Authors
- Fava, M.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2003-04
- Volume
- 53
- Issue
- 8
- Pages
- 649-659
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W2070828096
- Cited by
- 1,380
- References
- 77
- Citations by year
- 2026: 48 · 2025: 60 · 2024: 78 · 2023: 76 · 2022: 90 · 2021: 87 · 2020: 102 · 2019: 91 · 2018: 77 · 2017: 60 · 2016: 71 · 2015: 65 · 2014: 69 · 2013: 84 · 2012: 63
- FWCI
- 1.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- treatment-resistant depression, antidepressant response, diagnostic criteria, comorbidities, psychiatric comorbidity
- MeSH terms
- Antidepressive Agents, Depressive Disorder, Major, Major Depressive Disorder, Drug Resistance, Electroconvulsive Therapy, Humans, Terminology as Topic, Psychotherapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diagnosis and definition of treatment-resistant depression. https://app.cochat.ai/papers/10.1016/s0006-3223(03)00231-2
- The paper
- Fava, M. (2003). Diagnosis and definition of treatment-resistant depression. Biological Psychiatry. https://doi.org/10.1016/s0006-3223(03)00231-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.